연구용 항체 및 시약 시장 규모, 점유율, 성장 분석 : 유형별, 용도별, 조사 분야별, 최종사용자별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)

Global Research Antibodies and Reagents Market size was valued at USD 13.3 billion in 2023 and is poised to grow from USD 14.22 billion in 2024 to USD 24.25 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The research antibodies and reagents market is on an upward trajectory, driven by the growing demand for high-quality antibodies essential for reproducible research. Key growth factors include the expansion of proteomics and genomics, increased R&D activities aimed at enhancing diagnostic and therapeutic outcomes, and strengthened collaborations between industry and academia. Additionally, rising investments from both profit and non-profit organizations, a focus on biomarker discovery, and government support are bolstering market growth. The shift towards personalized medicine and protein therapeutics further presents lucrative opportunities. However, challenges such as the time-consuming nature of antibody development and pricing pressures may impede progress, alongside emerging concerns over quality and reproducibility that need to be addressed during the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Research Antibodies And Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Research Antibodies And Reagents Market Segments Analysis

Global Research Antibodies and Reagents Market is segmented by Type, Application, Research Area, End User, Distribution Channel and region. Based on Type, the market is segmented into Antibodies and Reagents. Based on Application, the market is segmented into Enzyme-Linked Immunosorbent Assay, Western Blotting, Immunohistochemistry, Flow Cytometry, Polymerase Chain Reaction and Others. Based on Research Area, the market is segmented into Immunology, Cell & Molecular Biology, Neuroscience, Genomics & Proteomics, Biotechnology & Drug Discovery, Microbiology and Others. Based on End User, the market is segmented into Pharmaceutical and Biopharmaceutical Manufacturers, Academic And Research Institutes, Contract Research Organizations (CROs), Hospitals & Diagnostic Laboratories and Others. Based on Distribution Channel, the market is segmented into Direct Sales, Third Party Sales and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Research Antibodies And Reagents Market

The Global Research Antibodies and Reagents market is significantly influenced by the synergy between academic institutions and the research and development sectors of various businesses. This collaboration facilitates the transfer of knowledge and advancements in technology, enhancing innovation and research capabilities. As economic uncertainties rise and technological advancements accelerate, these partnerships have become increasingly prevalent. Market players are focusing on engaging with academic institutions to raise awareness among students and researchers about cutting-edge analytical technologies, reflecting the diverse applications of research-specific antibodies and reagents, which ultimately drives market growth and development.

Restraints in the Global Research Antibodies And Reagents Market

The Global Research Antibodies and Reagents market faces significant challenges due to the reproducibility crisis, which highlights the troubling realization that many findings in biomedical research fail to replicate, casting doubt on their validity. This issue primarily stems from inconsistencies in the quality of antibodies, largely arising from diverse production techniques. Furthermore, the absence of standardized definitions for reproducibility across antibody products and a lack of comprehensive validation standards exacerbate the problem. As a result, researchers encounter difficulties in obtaining reliable and consistent results, which can undermine trust in scientific conclusions drawn from these studies.

Market Trends of the Global Research Antibodies And Reagents Market

The Global Research Antibodies and Reagents market is poised for substantial growth as personalized medicine continues to revolutionize disease detection, categorization, and treatment-especially in oncology. With biopharmaceutical companies ramping up R&D investments in personalized medicine, projected to surge by 33% over the next five years, the demand for advanced antibodies and reagents is escalating. The need for rapid and highly sensitive techniques to analyze proteins and their post-translational modifications is critical for tailoring patient-specific therapies. Researchers are increasingly focusing on gene variants and their correlations with drug responses, underscoring the necessity for innovative tools in this evolving healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Research Antibodies and Reagents Market Size by Type & CAGR (2025-2032)

• Market Overview
• Antibodies
  • Products
  • Primary Antibodies
  • Secondary Antibodies
  • Source
  • Mouse
  • Rabbit
  • Goat
  • Rat
  • Others
  • Origin
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
• Reagents
  • Buffers & Solution
  • PBS (Phosphate Buffered Saline)
  • Blocking Buffers
  • Dilution Buffers
  • Wash Buffers
  • Chemiluminescent Reagents

Global Research Antibodies and Reagents Market Size by Application & CAGR (2025-2032)

• Market Overview
• Enzyme-Linked Immunosorbent Assay
• Western Blotting
• Immunohistochemistry
• Flow Cytometry
• Polymerase Chain Reaction
• Others

Global Research Antibodies and Reagents Market Size by Research Area & CAGR (2025-2032)

• Market Overview
• Immunology
• Cell & Molecular Biology
• Neuroscience
• Genomics & Proteomics
• Biotechnology & Drug Discovery
• Microbiology
• Others

Global Research Antibodies and Reagents Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biopharmaceutical Manufacturers
• Academic And Research Institutes
• Contract Research Organizations (CROs)
• Hospitals & Diagnostic Laboratories
• Others

Global Research Antibodies and Reagents Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Direct Sales
• Third Party Sales
• Others

Global Research Antibodies and Reagents Market Size & CAGR (2025-2032)

• North America (Type, Application, Research Area, End User, Distribution Channel)
  • US
  • Canada
• Europe (Type, Application, Research Area, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, Research Area, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, Research Area, End User, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, Research Area, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteintech Group, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jackson Immuno Research Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santa Cruz Biotechnology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Atlas Antibodies AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SouthernBiotech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations